Medical and Pharmaceutical Industry - Market Research Report

The global   circulating tumor cells (CTCs) market   size was estimated at USD 12.61 billion in 2024 and is projected to reach USD 24.96 billion by 2030, expanding at a CAGR of 12.2% from 2025 to 2030. CTCs have gained significant traction in cancer diagnostics due to their noninvasive nature and enhanced diagnostic efficiency, making them a promising modality for early cancer detection and disease monitoring. Key Market Trends & Insights North America captured the largest market share of 40.91% in 2024. By technology, the CTC detection and enrichment methods segment accounted for the largest revenue share of 40.92% in 2024. By application, clinical segment dominated the market and captured the largest revenue share in 2024. By product, the kits & reagents segment dominated the market and accounted for the largest revenue share of 45.34% in 2024. By specimen, the blood segment dominated the market and accounted for the largest revenue share of 48.13% in 2024. By end-us...

The global   catheter market   size was estimated at USD 58.16 billion in 2024 and is projected to reach USD 85.19 billion by 2030, expanding at a CAGR of 6.60% from 2025 to 2030. The rising incidence of chronic conditions—including neurological, cardiovascular, and urological disorders—that require hospitalization continues to significantly drive market growth. Key Market Trends & Insights North America accounted for 31.61% of the global market share in 2024 and is expected to maintain its leading position throughout the forecast period. The U.S. remains the dominant market within North America, supported by advanced healthcare infrastructure and growing adoption of catheter-based procedures. By product, the cardiovascular catheter segment led the market with a 27.97% revenue share in 2024. By end use, hospital stores dominated the market, contributing the highest revenue share in 2024. Market Size & Forecast 2024 Market Size: USD 58.16 Billion 2030 Projected Market S...

The global   blood pressure monitoring devices market   size was estimated at USD 3.8 billion in 2024 and is projected to reach USD 6.7 billion by 2030, expanding at a CAGR of 9.8% from 2025 to 2030. The increasing prevalence of hypertension, largely driven by changing lifestyles and rising obesity rates, remains a major factor fueling market growth throughout the forecast period. Key Market Trends & Insights North America dominated the global market with over 36.0% share in 2024. The U.S. accounted for the largest share within the North American market. By device type, the non-smart/traditional segment held the leading share of over 56.7% in 2024. By end use, the hospital segment accounted for 51.2% share in 2024. Market Size & Forecast 2024 Market Size: USD 3.8 Billion 2030 Projected Market Size: USD 6.7 Billion CAGR (2025–2030): 9.8% North America: Largest regional market in 2024 According to the World Health Organization (WHO), around 1.28 billion people worldwide ...

The global   hyperspectral imaging systems market   was valued at USD 14.1 billion in 2023 and is projected to reach USD 28.63 billion by 2030, expanding at a CAGR of 10.7% from 2024 to 2030. The increasing adoption of hyperspectral imagery systems across diverse sectors—including R&D, healthcare, defense, food processing, night vision, and remote sensing—is driving significant market demand. Key Market Trends & Insights North America accounted for the largest share of over 30.0% in 2023. The U.S. market is anticipated to witness steady growth throughout the forecast period. By product, the camera segment held the largest share of over 71.8% in 2023. By technology, the snapshot segment dominated the market in 2023. By application, the military segment led the market with over 31.7% share in 2023. Market Size & Forecast 2023 Market Size: USD 14.1 Billion 2030 Market Size: USD 28.63 Billion CAGR (2024–2030): 10.7% North America: Largest regional market in 2023 Asia P...

The global   biological safety testing products & services market   size was estimated at USD 4.89 billion in 2024 and is projected to reach USD 12.09 billion by 2033, expanding at a CAGR of 10.64% from 2025 to 2033. The increasing prevalence of target diseases, coupled with the rising production of next-generation biologics by biotechnology and pharmaceutical companies, continues to propel market growth. These factors are strengthening the demand for reliable, accurate, and scalable biosafety testing solutions across the industry. Key Market Trends & Insights North America accounted for the largest market share, representing 36.59% of the global market in 2024. The U.S. market is expected to observe robust growth throughout the forecast period. By product, the reagents & kits segment dominated with a 39.69% market share in 2024. Based on application, the vaccines & therapeutics segment held the highest share in 2024. By test type, endotoxin tests represented t...

The global   biobanks market   was valued at USD 81.29 billion in 2024 and is projected to reach USD 126.69 billion by 2030, expanding at a CAGR of 7.85% from 2025 to 2030. This growth is primarily driven by substantial investments in R&D for advanced therapies, including regenerative medicine, personalized medicine, and cancer genomic studies. Key Market Trends & Insights Europe biobanks industry accounted for the largest revenue share of 39.37% in 2024. The Asia Pacific biobanks industry is expected to witness the fastest CAGR over the forecast period. Based on product & services, the services segment dominated the market and accounted for the largest revenue share in 2024 and is anticipated to grow at the fastest CAGR during the forecast period. Based on biospecimen type, the human tissues segment captured the largest revenue share of 36.74% in 2024. Based on biobanks type, the physical/real biobanks segment dominated the market in 2024 and accounted for the lar...

The global   bioanalytical testing services market   size was valued at USD 4.80 billion in 2024 and is projected to reach USD 11.24 billion by 2033, expanding at a CAGR of 9.93% from 2025 to 2033. Market growth is primarily driven by rising drug development activities, increasing drug approval volumes, growing therapeutic complexity, and the accelerated shift toward outsourcing specialized testing services. Key Market Trends & Insights North America accounted for the largest revenue share at 47.40% in 2024. The U.S. market contributed the highest share within the region. By molecule type, small molecules dominated with 55.67% revenue share in 2024. By test type, the bioequivalence segment emerged as the leading category in 2024. Market Size & Forecast 2024 Market Size: USD 4.80 Billion 2033 Market Size: USD 11.24 Billion CAGR (2025–2033): 9.93% North America: Largest regional market Asia-Pacific: Fastest-growing region The emergence of advanced therapeutic modalities—...

The global   astaxanthin market   was estimated at USD 1.69 billion in 2024 and is projected to reach USD 3.89 billion by 2030, expanding at a CAGR of 14.74% from 2025 to 2030. The rising demand for astaxanthin is driven by its increasing application across aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food & beverages. Growing consumer awareness regarding natural antioxidants and their health benefits continues to influence market expansion. Key Market Trends & Insights North America held the largest market share of 35.27% in 2024. The U.S. market is growing due to increasing adoption of natural antioxidant ingredients. By source, the natural segment accounted for 58.45% of overall revenue in 2024. By product, dried algae meal or biomass captured 25.12% share in 2024. By application, aquaculture & animal feed dominated with 46.07% share in 2024. Market Size & Forecast 2024 Market Size: USD 1.69 Billion 2030 Market Size Projection: U...

The global   hemodialysis and peritoneal dialysis market   was valued at USD 102.1 billion in 2023 and is projected to reach USD 185.88 billion by 2030, expanding at a CAGR of 9.1% from 2024 to 2030. Growth in this market is primarily driven by the shortage of organ donors, increasing incidence of acute kidney injury (AKI), risks associated with kidney transplantation, technological advancements, and strategic initiatives by major industry players to introduce innovative dialysis products and services. Key Market Trends & Insights North America held the largest revenue share of 38.25% in 2023. Asia Pacific is expected to record the fastest CAGR during the forecast period. Hospital-based end-use segment led the market with 76.75% revenue share in 2023. Service segment dominated the product category with a 56.61% share in 2023. Hemodialysis accounted for the highest share of 82.71% in 2023. Market Size & Forecast 2023 Market Size: USD 102.1 Billion 2030 Projected Market ...

The global   in vitro diagnostics (IVD) quality control market   size was estimated at USD 1.28 billion in 2023 and is projected to reach USD 1.59 billion by 2030, expanding at a CAGR of 3.2% from 2024 to 2030. The rise in the number of certified clinical laboratories offering reliable IVD-based diagnostic services has strengthened patient confidence, which continues to fuel market demand. Key Market Trends & Insights North America dominated the in vitro diagnostics quality control market with a 47.1% share in 2023. The U.S. accounted for a significant portion of the global market in 2023. By product, the controls segment led the market with a 48.3% share in 2023. By type, the quality controls segment captured the largest revenue share in 2023. By application, the immunochemistry segment held the largest revenue share in 2023. Market Size & Forecast 2023 Market Size: USD 1.28 Billion 2030 Projected Market Size: USD 1.59 Billion CAGR (2024–2030): 3.2% North America: Lar...

The global   flow cytometry market   was valued at approximately USD 4,684.2 million in 2024, and is expected to grow to around USD 7,013.1 million by 2030, expanding at a compound annual growth rate (CAGR) of 8.41% from 2025 to 2030. The main drivers behind this growth include rising incidences of cancer, immunodeficiency disorders, and infectious diseases, which are fueling demand for flow cytometry technologies. Key Market Trends & Insights North America dominated the flow cytometry market with the largest revenue share of 41.35% in 2024. The flow cytometry market in the U.S. is expected to experience at a robust CAGR between 2024 and 2030 By product, the instrument segment led the market with the largest revenue share of 35.30% in 2024. Based on technology, the cell-based segment led the market with the largest revenue share of 76.16% in 2024. Based on application, the clinical segment led the market with the largest revenue share of 45.34% in 2024. Based on end use, t...

The global   aesthetic medicine market   size was estimated at USD 89.64 billion in 2024 and is projected to reach USD 239.98 billion by 2033, expanding at a CAGR of 11.73% from 2025 to 2033. This strong growth is driven by the rising adoption of minimally invasive and noninvasive cosmetic procedures, along with a growing population seeking solutions for age-related concerns. Key Market Trends & Insights North America accounted for the largest revenue share at 33.74% in 2024. The aesthetic medicine industry in Canada is expected to register the fastest CAGR from 2025 to 2033. By procedure type, invasive procedures held the largest market share in 2024. By end use, clinics and aesthetic centers dominated the market with a 48.09% share in 2024. Market Size & Forecast 2024 Market Size: USD 89.64 Billion 2033 Projected Market Size: USD 239.98 Billion CAGR (2025–2033): 11.73% Largest Regional Market (2024): North America According to the ISAPS report, 17.42 million surgical...

The global   active pharmaceutical ingredients (API) market   size was estimated at USD 255.00 billion in 2024 and is projected to reach USD 359.45 billion by 2030, expanding at a CAGR of 5.8% from 2025 to 2030. Market growth is largely driven by rising global demand for pharmaceutical drugs, particularly in emerging economies, alongside the increasing burden of chronic diseases such as cancer, diabetes, and cardiovascular disorders. Advancements in biologics, biosimilars, and innovative drug formulations are further fueling the demand for specialized APIs. Additionally, the continual shift toward generic medicines and the rapid expansion of contract manufacturing organizations (CMOs) are significantly contributing to API production and distribution efficiency. Key Market Trends & Insights North America dominated the API market with a 38.04% revenue share in 2024. Asia Pacific is expected to register the fastest CAGR during the forecast period. Based on type of synthesis, ...

The global   surgical robotic services market   was valued at USD 1.53 billion in 2023 and is forecasted to reach USD 3.73 billion by 2030, expanding at a CAGR of 13.9% from 2024 to 2030. Market growth is primarily driven by the rising adoption of robotic technologies in surgical procedures, the increasing demand for specialized surgical expertise, and the growing need for remote monitoring and telesurgery solutions. Additionally, the shift toward cost-effective service models is further strengthening market expansion. Key Market Trends & Insights North America held the dominant position in the global surgical robotic services market, accounting for 49.85% of total revenue in 2023. The U.S. remained the leading contributor within the region. In terms of application, neurology is projected to grow the fastest, registering a CAGR of 22.5% over the forecast period. By end-use, inpatient facilities led the market with a 53.21% revenue share in 2023, due to increased adoption o...